Dermapharm Holding SE
OTC:DMPHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dermapharm Holding SE
OTC:DMPHF
|
DE |
|
H
|
HA Sustainable Infrastructure Capital Inc
F:6HA
|
US |
|
Bank Central Asia Tbk PT
OTC:PBCRY
|
ID |
|
H
|
Hong Kong and China Gas Co Ltd
XMUN:HCG
|
HK |
Wall St Price Targets
DMPHF Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMPHF is 65.03 USD with a low forecast of 56.67 USD and a high forecast of 80.33 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMPHF's stock price target?
Price Target
65.03
USD
According to Wall Street analysts, the average 1-year price target for DMPHF is 65.03 USD with a low forecast of 56.67 USD and a high forecast of 80.33 USD.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
10%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
9%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 9%.
